FDA Approved: VONJO — Original Application (Sobi, Inc.)

View source ↗

Summary

FDA approved VONJO (pacritinib) from Sobi, Inc. as the original NDA approval for the treatment of adults with myelofibrosis, including patients with severe thro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• VONJO (pacritinib)

Snippet

ORIG AP for VONJO (PACRITINIB)